Recent advances in hypertrophic cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Molecular Genetics
• Medical Imaging

Background:

• Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition requiring accurate diagnosis and management.
• Recent years have seen significant progress in understanding the genetic basis and phenotypic presentation of HCM.
• Existing diagnostic methods may not always distinguish HCM from other cardiac or metabolic disorders.

Purpose of the Study:

• To review recent advances in molecular genetics and cardiac imaging for hypertrophic cardiomyopathy.
• To highlight the utility of genetic testing and cardiovascular magnetic resonance (CMR) in HCM diagnosis and management.
• To discuss the impact of these advancements on clinical decision-making for HCM patients.

Main Methods:

• Review of current literature on molecular genetics and cardiac imaging techniques in HCM.
• Analysis of the applications of commercially available genetic testing for familial screening and differential diagnosis.
• Evaluation of cardiovascular magnetic resonance (CMR) for assessing hypertrophy, anatomy, and guiding invasive management.

Main Results:

• Genetic testing effectively identifies affected relatives in HCM families and differentiates HCM from phenocopies.
• Cardiovascular magnetic resonance (CMR) provides detailed assessment of hypertrophy and mitral valve apparatus anatomy.
• These diagnostic tools offer valuable information impacting decisions regarding invasive management strategies for HCM.

Conclusions:

• Molecular genetics and advanced cardiac imaging represent significant advancements in hypertrophic cardiomyopathy care.
• Genetic testing and CMR are crucial for accurate diagnosis, risk stratification, and guiding therapeutic interventions in HCM.
• Continued integration of these technologies promises improved patient outcomes in hypertrophic cardiomyopathy management.